Company Name | Astellas Pharma Taiwan, Inc. |
---|---|
Protocol Number | 9463-MA-1006 |
Title of Study | Non-interventional Study on the Safety and Efficacy of Micafungin for Prevention and Treatment of Fungal Infections in Pediatric Patients in Asia/Oceania – ERADICATE Study |
Primary Objective | The primary objective of this study is to evaluate the safety of micafungin when prescribed for prophylaxis or treatment of fungal infections in paediatric patients in Asia/Oceania. |
Number of Sites | 6 sites in Taiwan |
Period of Study | From:December, 2016 to:November, 2019 |
Number of Patients | 120人 |
IRB Approval Date | TBC |
Publication Plan / Date | TBC |